8-K: Current report filing
Published on April 30, 2008
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT PURSUANT
TO
SECTION 13 OR 15(d) OF THE
SECURITIES
EXCHANGE ACT OF 1934
Date
of Report (Date of earliest event reported): April 28,
2008
OPKO
Health, Inc.
(Exact
Name of Registrant as Specified in Charter)
|
Delaware
(State
or other
jurisdiction
of
incorporation)
|
|
000-26648
(Commission
File
Number)
|
|
75-2402409
(IRS
Employer
Identification
No.)
|
4400
Biscayne Blvd
Suite 1180
Miami,
Florida 33137
(Address
of Principal Executive Offices)
Registrant’s
telephone number, including area code: (305) 575-4138
____________________________________________________
(Former
Name or Former Address, if Changed Since Last Report)
Check
the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2. below):
o
Written communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425)
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
| Item 5.02. |
Departure
of Directors or Certain Officers; Election of Directors; Appointment
of
Certain Officers; Compensatory Arrangements of Certain
Officers.
|
On
April
28, 2008, the Compensation Committee of the Board of Directors (the
"Compensation Committee") of OPKO Health, Inc. (the "Company") held a meeting
to
review certain compensation matters for its executive officers and non-executive
employees. At the meeting, the Compensation Committee granted stock options
to
certain of the Company's executive officers to purchase the number of shares
of
the Company’s common stock set forth opposite their name below:
|
Name
|
Shares
of Common Stock
|
|
Phillip
Frost, M.D., Chief Executive Officer and Chairman
|
300,000
|
|
Jane
Hsiao, Ph.D., Vice Chairman and Chief Technology Officer
|
250,000
|
|
Steven
D. Rubin, Executive Vice President - Administration
|
200,000
|
|
Rao
Uppaluri, Ph.D., Senior Vice President - Chief Financial
Officer
|
175,000
|
Each
stock option was granted effective as of April 28, 2008, with an exercise price
per share equal to $1.65, the closing per share price of the Company's common
stock as reported on the American Stock Exchange on April 28, 2008. The
Compensation Committee determined not to increase the base salaries paid to
its
executive officers from the levels set in 2007. The Compensation Committee
further determined that no annual cash bonus would be paid for the fiscal year
ended December 31, 2007.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant
has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
OPKO
Health, Inc.
|
||||
|
By:
|
/s/
Adam Logal
|
|||
|
Name:
|
Adam
Logal
|
|||
|
Title:
|
Executive
Director of Finance, Chief
|
|||
| Accounting Officer, Treasurer | ||||
Date:
April 30, 2008